new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing

November 2000

Merck will soon market new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing.

The new tabs come in two strengths...35 and 70 mg.

Patients taking 5 mg/d to prevent osteoporosis use the 35 mg tab.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

pharmacists as part of an "early warning system" to help identify problems with newly approved drugs
Oral Health Abreva, the first OTC product approved to speed HEALING of cold sores and fever blisters
Cardiology more patients taking ACE inhibitors
Osteoporosis new Fosamax (alendronate) tablets for ONCE-A-WEEK dosing
Osteoporosis treating osteoporosis in MEN
Osteoporosis Lead contamination in calcium supplements
Diabetes Glucophage XR, a new extended-release metformin tablet for once-a-day dosing
OTC Products Experts are now urging the FDA to ban the use of phenylpropanolamine (PPA) in OTC products
OTC Products Mercury thermometers will soon be a thing of the past
Influenza It turns out there WILL be enough flu vaccine to go around this season
Influenza Tamiflu is more effective if it's started earlier
Hematology & Oncology Trisenox, an injectable form of ARSENIC
Qvar (CUE-var) beclomethasone inhaler for asthma
inhaled steroids DON'T affect LONG-TERM growth in children
community pharmacy residencies
Women's Health new injectable contraceptive called Lunelle
OTC Products Pepcid Complete, the first H2-blocker and antacid combo for heartburn.
Ophthalmology Quixin, a new levofloxacin eye drop for conjunctivitis.
new ways to manage hypersexuality in dementia patients